Home
>
National Drug Code (NDC)
>
Exjade
Exjade - 0078-0469-15 - (deferasirox)
Drug Information of Exjade
| Product NDC: | 0078-0469 |
| Proprietary Name: | Exjade |
| Non Proprietary Name: | deferasirox |
| Active Ingredient(s): | 250 mg/1 & nbsp; deferasirox |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FOR SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Exjade
| Product NDC: | 0078-0469 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021882 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20051130 |
Package Information of Exjade
| Package NDC: | 0078-0469-15 |
| Package Description: | 30 TABLET, FOR SUSPENSION in 1 BOTTLE (0078-0469-15) |
NDC Information of Exjade
| NDC Code | 0078-0469-15 |
| Proprietary Name | Exjade |
| Package Description | 30 TABLET, FOR SUSPENSION in 1 BOTTLE (0078-0469-15) |
| Product NDC | 0078-0469 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | deferasirox |
| Dosage Form Name | TABLET, FOR SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20051130 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | DEFERASIROX |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Iron Chelating Activity [MoA],Iron Chelator [EPC] |
